Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Francesca Torriani

    TitleProfessor Of Clinical
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address200 W. Arbor Drive #8951
    CA San Diego 92103
    Phone619-543-8258
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cachay ER, Ballard C, Colwell B, Torriani F, Hicks C, Mathews WC. Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment. AIDS Res Ther. 2017 Sep 20; 14(1):56. PMID: 28931406.
        View in: PubMed
      2. Cachay ER, Wyles D, Hill L, Ballard C, Torriani F, Colwell B, Kuo A, Schooley R, Mathews CW. The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care. Open Forum Infect Dis. 2015 Dec; 2(4):ofv168. PMID: 26697509; PMCID: PMC4683297.
      3. Cachay ER, Hill L, Wyles D, Colwell B, Ballard C, Torriani F, Mathews WC. The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care. PLoS One. 2014; 9(7):e102883. PMID: 25036553; PMCID: PMC4103859.
      4. Cachay ER, Wyles DL, Torriani F, Ballard C, Colwell B, Lin JC, Hill L, Mathews WC. High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen. AIDS. 2013 Nov 28; 27(18):2893-7. PMID: 23842130.
        View in: PubMed
      5. Hulgan T, Stein JH, Cotter BR, Murdock DG, Ritchie MD, Dube MP, Gerschenson M, Haas DW, Torriani F. Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1293-9. PMID: 23944767; PMCID: PMC3785797.
      6. Cachay ER, Hill L, Ballard C, Colwell B, Torriani F, Wyles D, Mathews WC. Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model. AIDS Res Ther. 2013 Mar 28; 10(1):9. PMID: 23537147; PMCID: PMC3620560.
      7. Tehrani DM, Russell D, Brown J, Boynton-Delahanty K, Quan K, Gibbs L, Braddock G, Zaroda T, Koopman M, Thompson D, Nichols A, Cui E, Liu C, Cohen S, Rubin Z, Pegues D, Torriani F, Datta R, Huang SS. Discord among performance measures for central line-associated bloodstream infection. Infect Control Hosp Epidemiol. 2013 Feb; 34(2):176-83. PMID: 23295564.
        View in: PubMed
      8. Opravil M, Rodriguez-Torres M, Rockstroh J, Snoeck E, Chung RT, Tietz A, Torriani F. The dose-response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV. HIV Clin Trials. 2012 Jan-Feb; 13(1):33-45. PMID: 22306586.
        View in: PubMed
      9. Cachay ER, Wyles DL, Goicoechea M, Torriani F, Ballard C, Colwell B, Gish RG, Mathews WC. Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment. AIDS Res Ther. 2011 Aug 10; 8:29. PMID: 21831314; PMCID: PMC3163174.
      10. Murphy RL, Berzins B, Zala C, Fichtenbaum C, Dube MP, Guaraldi G, Torriani F, Belsey E, Mitchell C, Stein JH. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. AIDS. 2010 Mar 27; 24(6):885-90. PMID: 19952712.
        View in: PubMed
      11. Potenza B, Deligencia M, Estigoy B, Faraday E, Snyder A, Angle N, Schwartz A, Chang L, Hackett J, Minokadeh A, Madani M, MacAulay K, Ramamoorthy S, Blaner L, James C, Bansal V, Torriani F, Coimbra R. Lessons learned from the institution of the Surgical Care Improvement Project at a teaching medical center. Am J Surg. 2009 Dec; 198(6):881-8. PMID: 19969146.
        View in: PubMed
      12. Maragakis LL, Chaiwarith R, Srinivasan A, Torriani F, Avdic E, Lee A, Ross TR, Carroll KC, Perl TM. Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl. Emerg Infect Dis. 2009 Jan; 15(1):12-8. PMID: 19116043; PMCID: PMC2660711.
      13. Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani F. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008 Dec; 2(6):464-471. PMID: 19956354.
        View in: PubMed
      14. Torriani F, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008 Aug 12; 52(7):569-76. PMID: 18687253; PMCID: PMC2603599.
      15. Opravil M, Sasadeusz J, Cooper DA, Rockstroh JK, Clumeck N, Clotet B, Montaner J, Torriani F, Depamphilis J, Dieterich DT. Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection. J Acquir Immune Defic Syndr. 2008 Jan 01; 47(1):36-49. PMID: 18156990.
        View in: PubMed
      16. Dore GJ, Torriani F, Rodriguez-Torres M, Bräu N, Sulkowski M, Lamoglia RS, Tural C, Clumeck N, Nelson MR, Mendes-Correa MC, Godofsky EW, Dieterich DT, Yetzer E, Lissen E, Cooper DA. Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection. AIDS. 2007 Jul 31; 21(12):1555-9. PMID: 17630550.
        View in: PubMed
      17. Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani F, Tebas P, Li Y, Hodis HN. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007 May 31; 21(9):1137-45. PMID: 17502724.
        View in: PubMed
      18. Thompson K, Torriani F. Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection. Curr HIV/AIDS Rep. 2006 Sep; 3(3):107-12. PMID: 16970836.
        View in: PubMed
      19. Hornberger J, Torriani F, Dieterich DT, Bräu N, Sulkowski MS, Torres MR, Green J, Patel K. Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection. J Clin Virol. 2006 Aug; 36(4):283-91. PMID: 16765638.
        View in: PubMed
      20. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani F, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006 Jun; 43(6):1317-25. PMID: 16729309.
        View in: PubMed
      21. Schrier RD, Song MK, Smith IL, Karavellas MP, Bartsch DU, Torriani F, Garcia CR, Freeman WR. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis. Retina. 2006 Feb; 26(2):165-9. PMID: 16467672.
        View in: PubMed
      22. Currier JS, Kendall MA, Henry WK, Torriani F, Hodis HN. Response to: 'carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients'. AIDS. 2006 Jan 09; 20(2):311. PMID: 16511437.
        View in: PubMed
      23. Mathews WC, Caperna JC, Barber RE, Torriani F, Miller LG, May S, McCutchan JA. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr. 2005 Oct 01; 40(2):155-60. PMID: 16186732.
        View in: PubMed
      24. Aberg JA, Zackin RA, Brobst SW, Evans SR, Alston BL, Henry WK, Glesby MJ, Torriani F, Yang Y, Owens SI, Fichtenbaum CJ. A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Res Hum Retroviruses. 2005 Sep; 21(9):757-67. PMID: 16218799.
        View in: PubMed
      25. Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani F, Schouten J, Mickelberg K, Li Y, Hodis HN. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005 Jun 10; 19(9):927-33. PMID: 15905673; PMCID: PMC1373680.
      26. Torriani F, Chung RT. Peginterferon alpha-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections. ACP J Club. 2005 Jan-Feb; 142(1):A12; author reply A13. PMID: 15656540.
        View in: PubMed
      27. Mauss S, Valenti W, DePamphilis J, Duff F, Cupelli L, Passe S, Solsky J, Torriani F, Dieterich D, Larrey D. Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS. 2004 Sep 03; 18(13):F21-5. PMID: 15316334.
        View in: PubMed
      28. Torriani F, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004 Jul 29; 351(5):438-50. PMID: 15282351.
        View in: PubMed
      29. El-Bradey MH, Cheng L, Song MK, Torriani F, Freeman WR. Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach. Retina. 2004 Jun; 24(3):376-82. PMID: 15187659; PMCID: PMC1378115.
      30. Cotter BR, Torriani F. Cardiovascular effects of antiretroviral therapy and noninvasive assessments of cardiovascular disease in HIV infection. Cardiovasc Toxicol. 2004; 4(3):281-6. PMID: 15470275.
        View in: PubMed
      31. Torriani F, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS. Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection. J Infect Dis. 2003 Nov 15; 188(10):1498-507. PMID: 14624375.
        View in: PubMed
      32. Song MK, Azen SP, Buley A, Torriani F, Cheng L, Chaidhawangul S, Ozerdem U, Scholz B, Freeman WR. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 2003 Oct; 136(4):696-702. PMID: 14516810.
        View in: PubMed
      33. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani F, Lennox JL, Dube MP, MacGregor RR, Currier JS. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis. 2003 Apr 01; 187(7):1046-52. PMID: 12660918.
        View in: PubMed
      34. Lalezari J, Lindley J, Walmsley S, Kuppermann B, Fisher M, Friedberg D, Lalonde R, Matheron S, Nieto L, Torriani F, Van Syoc R, Sutton MA, Buhles W, Stempien MJ. A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis. J Acquir Immune Defic Syndr. 2002 Aug 01; 30(4):392-400. PMID: 12138345.
        View in: PubMed
      35. Kurup A, Torriani F. Therapy and Prevention of Cytomegalovirus Retinitis. Curr Infect Dis Rep. 2001 Aug; 3(4):371-377. PMID: 11470029.
        View in: PubMed
      Francesca's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _